iORGANtech

iOrganTech is a Taiwan-based biotechnology company specializing in the development of exosome-based therapeutics for regenerative medicine. Founded in 2020 by Dr. Shie-Liang Lin, the company leverages a proprietary platform to isolate and purify exosomes from mesenchymal stem cells (MSCs) to treat degenerative and inflammatory conditions. Their primary therapeutic pipeline includes candidates for osteoarthritis and chronic kidney disease, aiming to provide cell-free regenerative therapies that offer higher safety and stability compared to traditional stem cell treatments. In addition to its clinical programs, iOrganTech develops exosome-enhanced products for the aesthetic and skincare markets, focusing on skin rejuvenation and hair loss. The company is recognized as a pioneer in the Taiwanese exosome industry, establishing standardized manufacturing processes for extracellular vesicles.